Park, Youn Young

Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma. [electronic resource] - Medicine Aug 2019 - e16709 p. digital

Publication Type: Journal Article; Observational Study

1536-5964

10.1097/MD.0000000000016709 doi


AC133 Antigen--metabolism
Aged
Biomarkers, Tumor--genetics
Colorectal Neoplasms--genetics
Disease-Free Survival
Female
Humans
Male
Middle Aged
Neoplasm Staging
Neoplastic Stem Cells--metabolism
Retrospective Studies